L-735,524
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for L-735,524, covering 2016-12-14 to 2016-12-14. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113) [NA]